Literature DB >> 9550380

Immunohistochemical analysis of in vivo patterns of TRAF-3 expression, a member of the TNF receptor-associated factor family.

S Krajewski1, J M Zapata, M Krajewska, T VanArsdale, A Shabaik, R D Gascoyne, J C Reed.   

Abstract

An immunohistochemical approach was used to explore the in vivo expression of TNF receptor-associated factor 3 (TRAF-3), a putative signaling protein that binds to the cytosolic domains of CD30, CD40, and lymphotoxin-beta receptors. TRAF-3 immunostaining was detected in many types of cells throughout the human body. TRAF-3 immunostaining was only rarely present in thymocytes but was found in the thymic epithelioreticular cells. Lymphocytes in the bone marrow were also typically TRAF-3 immunonegative, whereas myeloid progenitor cells and megakaryocytes were often TRAF-3 positive. Peripheral blood lymphocytes were mostly TRAF-3 immunonegative, while granulocytes were TRAF-3 immunopositive. Monocytes were strongly immunostained for TRAF-3, but macrophages in nodes typically contained little or no TRAF-3 immunoreactivity. Some lymphocytes within the germinal centers of secondary lymphoid follicles in normal and reactive nodes were TRAF-3 immunopositive, as were occasional interfollicular lymphocytes in the T cell regions of these organs, but most lymphocytes appeared to be TRAF-3 immunonegative or stained only weakly. Plasma cells, however, were strongly TRAF-3 positive. Stimulation of PBLs with anti-CD3 Ab induced marked increases in the steady state levels of TRAF-3 protein in vitro as determined by immunoblotting, while levels of TRAF-2 were unchanged, implying a dynamic regulation of TRAF-3 expression. The findings establish for the first time the cell type- and differentiation-specific patterns of expression of a member of the TRAF family of proteins.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9550380

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  16 in total

1.  Mixed lineage kinase-3 stabilizes and functionally cooperates with TRIBBLES-3 to compromise mitochondrial integrity in cytokine-induced death of pancreatic beta cells.

Authors:  Rohan K Humphrey; Christina J Newcomb; Shu-Mei A Yu; Ergeng Hao; Doris Yu; Stan Krajewski; Keyong Du; Ulupi S Jhala
Journal:  J Biol Chem       Date:  2010-04-26       Impact factor: 5.157

2.  Rapid local expression of interleukin-12, tumor necrosis factor alpha, and gamma interferon after cutaneous Francisella tularensis infection in tularemia-immune mice.

Authors:  S Stenmark; D Sunnemark; A Bucht; A Sjöstedt
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

3.  Expression of Bcl-2 family member Bid in normal and malignant tissues.

Authors:  Maryla Krajewska; Juan M Zapata; Ivo Meinhold-Heerlein; Hirad Hedayat; Anne Monks; Herta Bettendorf; Ahmed Shabaik; Lukas Bubendorf; Olli-P Kallioniemi; Hoguen Kim; Guido Reifenberger; John C Reed; Stanislaw Krajewski
Journal:  Neoplasia       Date:  2002 Mar-Apr       Impact factor: 5.715

4.  Functions of type II pneumocyte-derived vascular endothelial growth factor in alveolar structure, acute inflammation, and vascular permeability.

Authors:  Marco Mura; Matthew Binnie; Bing Han; Chengjin Li; Cristiano F Andrade; Atsushi Shiozaki; Yu Zhang; Napoleone Ferrara; David Hwang; Thomas K Waddell; Shaf Keshavjee; Mingyao Liu
Journal:  Am J Pathol       Date:  2010-02-18       Impact factor: 4.307

5.  The Chx10-Traf3 Knockout Mouse as a Viable Model to Study Neuronal Immune Regulation.

Authors:  Jami M Gurley; Grzegorz B Gmyrek; Elizabeth A Hargis; Gail A Bishop; Daniel J J Carr; Michael H Elliott
Journal:  Cells       Date:  2021-08-12       Impact factor: 7.666

6.  Lymphocyte-specific TRAF3 transgenic mice have enhanced humoral responses and develop plasmacytosis, autoimmunity, inflammation, and cancer.

Authors:  Juan M Zapata; David Llobet; Maryla Krajewska; Sophie Lefebvre; Christina L Kress; John C Reed
Journal:  Blood       Date:  2008-12-12       Impact factor: 22.113

7.  TRAF-4 expression in epithelial progenitor cells. Analysis in normal adult, fetal, and tumor tissues.

Authors:  M Krajewska; S Krajewski; J M Zapata; T Van Arsdale; R D Gascoyne; K Berern; D McFadden; A Shabaik; J Hugh; A Reynolds; C V Clevenger; J C Reed
Journal:  Am J Pathol       Date:  1998-06       Impact factor: 4.307

Review 8.  Multiple roles of TRAF3 signaling in lymphocyte function.

Authors:  Gail A Bishop; Ping Xie
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

Review 9.  Alternative splicing in the NF-kappaB signaling pathway.

Authors:  Joshua R Leeman; Thomas D Gilmore
Journal:  Gene       Date:  2008-07-22       Impact factor: 3.688

10.  Tumor necrosis factor receptor-associated factor (TRAF)2 represses the T helper cell type 2 response through interaction with NFAT-interacting protein (NIP45).

Authors:  R Lieberson; K A Mowen; K D McBride; V Leautaud; X Zhang; W K Suh; L Wu; L H Glimcher
Journal:  J Exp Med       Date:  2001-07-02       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.